Ausgabe 2/2018
Inhalt (27 Artikel)
Health-related quality of life of Iranian breast cancer patients: a meta-analysis and systematic review
Salehoddin Bouya, Maryam koochakzai, Hosein Rafiemanesh, Abbas Balouchi, Safiyeh Taheri, Mahin Badakhsh, Mahnaz Didehvar
Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
Michael J. Duffy, Naoise C. Synnott, John Crown
Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
Tia H. Turner, Mohammad A. Alzubi, Sahib S. Sohal, Amy L. Olex, Mikhail G. Dozmorov, J. Chuck Harrell
Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
Nuray Erin, Nur Ogan, Azmi Yerlikaya
Correction to: Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
Nuray Erin, Nur Ogan, Azmi Yerlikaya
Circulating microRNAs from the miR-106a–363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer
Minghui Li, Yan Zhou, Tiansong Xia, Xin Zhou, Zebo Huang, Huo Zhang, Wei Zhu, Qiang Ding, Shui Wang
A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients
Hao Cai, Wenbing Guo, Shuobo Zhang, Na Li, Xianlong Wang, Huaping Liu, Rou Chen, Shanshan Wang, Zheng Guo, Jing Li
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer
Raksha R. Bhat, Puja Yadav, Debashish Sahay, Dharmendra K. Bhargava, Chad J. Creighton, Sahar Yazdanfard, Ahmed Al-rawi, Vikas Yadav, Lanfang Qin, Sarmistha Nanda, Vidyalakshmi Sethunath, Xiaoyong Fu, Carmine De Angelis, Vihang A. Narkar, C. Kent Osborne, Rachel Schiff, Meghana V. Trivedi
The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene
Yanchun Li, Mateusz Opyrchal, Song Yao, Xuan Peng, Li Yan, Hossam Jabbour, Thaer Khoury
Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
P. Roy, A. Leizorovicz, R. Villet, C. Mercier, J. Y. Bobin
Radial scar on image-guided breast biopsy: is surgical excision necessary?
Wendy Yen Yun Chou, Deborah J. Veis, Rebecca Aft
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
Sally Agersborg, Christopher Mixon, Thanh Nguyen, Sramila Aithal, Sucha Sudarsanam, Forrest Blocker, Lawrence Weiss, Robert Gasparini, Shiping Jiang, Wayne Chen, Gregory Hess, Maher Albitar
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients
Emanuela Risi, Andrea Grilli, Ilenia Migliaccio, Chiara Biagioni, Amelia McCartney, Cristina Guarducci, Martina Bonechi, Matteo Benelli, Stefania Vitale, Laura Biganzoli, Silvio Bicciato, Angelo Di Leo, Luca Malorni
Prediction of breast cancer risk with volatile biomarkers in breath
Michael Phillips, Renee N. Cataneo, Jose Alfonso Cruz-Ramos, Jan Huston, Omar Ornelas, Nadine Pappas, Sonali Pathak
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00
Elisabetta Munzone, Kathryn P. Gray, Caterina Fumagalli, Elena Guerini-Rocco, István Láng, Thomas Ruhstaller, Lorenzo Gianni, Roswitha Kammler, Giuseppe Viale, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Meredith M. Regan, Aron Goldhirsch, Massimo Barberis, Marco Colleoni
Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011
Lauren E. Wilson, Craig Evan Pollack, Melissa A. Greiner, Michaela A. Dinan
Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database
Fernando A. Angarita, Sergio A. Acuna, Erin Cordeiro, Ahmad Elnahas, Subir Sutradhar, Timothy Jackson, Tulin D. Cil
Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis
Kathrin Thöne, Anja Rudolph, Nadia Obi, Jenny Chang-Claude, Dieter Flesch-Janys
Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening
Francesca Caumo, Giovanna Romanucci, Kylie Hunter, Manuel Zorzi, Silvia Brunelli, Petra Macaskill, Nehmat Houssami
Mutational analysis of candidate genes in Israeli male breast cancer cases
Hagit Schayek, Hila Korach, Yael Laitman, Rinat Bernstein-Molho, Eitan Friedman
Breast cancer survival, survival disparities, and guideline-based treatment
Deirdre A. Hill, Sarah Friend, Lesley Lomo, Charles Wiggins, Marc Barry, Eric Prossnitz, Melanie Royce
Validation of a personalized risk prediction model for contralateral breast cancer
Marzana Chowdhury, David Euhus, Banu Arun, Chris Umbricht, Swati Biswas, Pankaj Choudhary
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing
Kelly Kyker-Snowman, Bracha Erlanger Avigdor, Mansoor Nasim, Ashley Cimino-Mathews, Sarah J. Wheelan, Pedram Argani, Ben Ho Park
Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress
Shatakshee Chatterjee, Rohan Chaubal, Arindam Maitra, Nilesh Gardi, Amit Dutt, Sudeep Gupta, Rajendra A. Badwe, Partha P. Majumder, Priyanka Pandey
Receptor conversion in breast cancer patients with liver metastases after hepatectomy might affect survival
Kadri Altundag